SNX29 Activators
Phorbol 12-myristate 13-acetate, known for its role in activating protein kinase C, affects the phosphorylation state of proteins, thereby potentially modifying the operational dynamics of SNX29. Forskolin operates by raising cAMP levels, which can have a cascading effect on cellular communication, impacting the processes in which SNX29 is involved. Ionomycin's ability to increase intracellular calcium levels shifts the landscape of calcium-dependent signaling, affecting proteins like SNX29 that are implicated in endosomal sorting.
Epidermal Growth Factor, through its activation of the EGF receptor, triggers a network of signaling that intersects with endocytic pathways, potentially influencing SNX29's role within them. Autophagy-inhibiting agents such as 3-MA indirectly affect the cell's recycling mechanisms, which could lead to alterations in SNX29's activity. The inhibition of phospholipase C by U73122, and the disruption of PI3K pathways by compounds like Wortmannin, also have implications for membrane trafficking and, by extension, SNX29's function. Additionally, genistein's inhibition of tyrosine kinases can modify a suite of signaling pathways that may touch upon the sorting nexin's activity. Disruptors of cellular scaffolding, such as nocodazole and cytochalasin D, which target microtubules and actin filaments respectively, alter the structural context required for proper functioning of SNX29. Monensin and Chlorpromazine, by modulating endosomal pH and clathrin-mediated endocytosis, demonstrate the intricate interplay between cellular processes and the potential modulation of SNX29.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C (PKC), which can modulate the sorting nexin family proteins by altering their phosphorylation state and function. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Increases intracellular calcium levels, which can affect sorting nexin proteins by altering calcium-dependent signaling pathways. | ||||||
Autophagy Inhibitor, 3-MA | 5142-23-4 | sc-205596 sc-205596A | 50 mg 500 mg | $65.00 $261.00 | 113 | |
Inhibits autophagy through PI3K inhibition, which can lead to increased endocytic recycling, potentially influencing SNX29 activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
PI3K inhibitor that could affect endosomal sorting and trafficking, potentially altering SNX29 activity. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Inhibits tyrosine kinases and could modify signaling pathways involving SNX29. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Disrupts microtubule polymerization, potentially impacting trafficking routes and SNX29's function within them. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Inhibits actin polymerization, which could affect membrane curvature and trafficking processes that involve SNX29. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Ionophore that disrupts endosomal pH gradient and can influence endosomal sorting, where SNX29 may play a role. | ||||||
Chlorpromazine | 50-53-3 | sc-357313 sc-357313A | 5 g 25 g | $61.00 $110.00 | 21 | |
Blocks clathrin-mediated endocytosis, potentially affecting sorting nexin family protein function including SNX29. | ||||||